Cargando…
Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application
Background: Multiple sclerosis (MS) afflicts more than 2.5 million individuals worldwide and this number is increasing over time. Within the past years, a great number of disease-modifying treatments have emerged; however, efficacious treatments and a cure for MS await discovery. Thymosins, soluble...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104151/ https://www.ncbi.nlm.nih.gov/pubmed/30317071 http://dx.doi.org/10.1016/j.msard.2018.09.035 |